RU2004108122A - Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя - Google Patents

Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя Download PDF

Info

Publication number
RU2004108122A
RU2004108122A RU2004108122/15A RU2004108122A RU2004108122A RU 2004108122 A RU2004108122 A RU 2004108122A RU 2004108122/15 A RU2004108122/15 A RU 2004108122/15A RU 2004108122 A RU2004108122 A RU 2004108122A RU 2004108122 A RU2004108122 A RU 2004108122A
Authority
RU
Russia
Prior art keywords
methods
application
amylopectin
mol
hyperbranched
Prior art date
Application number
RU2004108122/15A
Other languages
English (en)
Other versions
RU2303984C2 (ru
Inventor
Клаус ЗОММЕРМЕЙЕР (DE)
Клаус Зоммермейер
Original Assignee
Супрамол Парентерал Коллоидс Гмбх (De)
Супрамол Парентерал Коллоидс Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Супрамол Парентерал Коллоидс Гмбх (De), Супрамол Парентерал Коллоидс Гмбх filed Critical Супрамол Парентерал Коллоидс Гмбх (De)
Publication of RU2004108122A publication Critical patent/RU2004108122A/ru
Application granted granted Critical
Publication of RU2303984C2 publication Critical patent/RU2303984C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026Blood substitute; Oxygen transporting formulations; Plasma extender
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/718Starch or degraded starch, e.g. amylose, amylopectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/20Amylose or amylopectin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B35/00Preparation of derivatives of amylopectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dentistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (7)

1. Сверхразветвленный амилопектин со средней степенью разветвленности, выраженной в мол.% ангидроглюкозы, несущей точки разветвления, составляющей от более 10 до 25 мол.%, и средневзвешенной молекулярной массой ММ в интервале от 40000 до 800000 Д, и его производные, для применения в способах хирургического или терапевтического лечения человека или животного, или в диагностических методах.
2. Сверхразветвленный амилопектин по п.1 в качестве объемного плазмозаменителя.
3. Сверхразветвленный амилопектин по п.1 для улучшения микроциркуляции.
4. Сверхразветвленный амилопектин по п.1 для облегчения седиментации при выделении клеток в связи с лейкаферезом.
5. Сверхразветвленный амилопектин по п.1 для низкотемпературного хранения компонентов крови, таких как эритроцитов или гранулоцитов.
6. Сверхразветвленный амилопектин по любому из предшествующих пунктов, средняя степень разветвленности которого находится в интервале от 11 до 16 мол.%, а молекулярная масса имеет значение от 90000 до 300000 Д.
7. Сверхразветвленный амилопектин по любому из пп.1-5, средняя степень разветвленности которого находится в интервале от 13 до 16 мол.%, а молекулярная масса имеет значение от 120000 до 250000 Д.
RU2004108122/15A 2001-08-22 2002-08-06 Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя RU2303984C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141099 2001-08-22
DE10141099.9 2001-08-22

Publications (2)

Publication Number Publication Date
RU2004108122A true RU2004108122A (ru) 2005-03-27
RU2303984C2 RU2303984C2 (ru) 2007-08-10

Family

ID=7696220

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004108122/15A RU2303984C2 (ru) 2001-08-22 2002-08-06 Сверхразветвленный амилопектин для применения в способах хирургического или терапевтического лечения млекопитающих, или в диагностических методах, особенно для применения в качестве объемного плазмозаменителя

Country Status (20)

Country Link
US (1) US7393841B2 (ru)
EP (1) EP1421120B1 (ru)
JP (1) JP2005501930A (ru)
KR (1) KR100898528B1 (ru)
CN (1) CN100390203C (ru)
AT (1) ATE360651T1 (ru)
AU (1) AU2002325398B2 (ru)
CA (1) CA2456507C (ru)
DE (2) DE10235954A1 (ru)
DK (1) DK1421120T3 (ru)
ES (1) ES2283585T3 (ru)
HK (1) HK1068356A1 (ru)
HU (1) HUP0401188A3 (ru)
MX (1) MXPA04001606A (ru)
PL (1) PL209763B1 (ru)
PT (1) PT1421120E (ru)
RO (1) RO122279B1 (ru)
RS (1) RS51420B (ru)
RU (1) RU2303984C2 (ru)
WO (1) WO2003018639A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
DE10237442B4 (de) * 2002-08-16 2004-08-19 Fresenius Kabi Deutschland Gmbh Hochverzweigte, niedrig substituierte Stärkeprodukte
DE10256558A1 (de) * 2002-12-04 2004-09-16 Supramol Parenteral Colloids Gmbh Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
CZ20033424A3 (cs) * 2003-12-16 2005-08-17 Parenteral, A. S. Náhražka krevní plazmy, výchozí produkt a způsob výroby výchozího produktu pro náhražku lidské krevní plazmy
FR2864088B1 (fr) * 2003-12-19 2006-04-28 Roquette Freres Polymeres solubles de glucose hautement branches
ATE540996T1 (de) 2005-06-06 2012-01-15 Univ British Columbia Polymerbasierter serumalbumin-ersatzstoff
EP1943908A1 (en) * 2006-12-29 2008-07-16 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Novel slowly digestible storage carbohydrate
CA2791416C (en) 2010-03-01 2018-05-15 The University Of British Columbia Derivatized hyperbranched polyglycerols
KR20190064653A (ko) * 2010-06-17 2019-06-10 가부시기가이샤하야시바라 풀루란 함유 분말과 그 제조방법 및 용도
AR095937A1 (es) * 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA928215A (en) 1969-08-08 1973-06-12 M. Brake Jon Process for the cryogenic preservation of blood and erythrocytes and products produced thereby
US4125492A (en) 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
US4111199A (en) * 1977-03-31 1978-09-05 Isaac Djerassi Method of collecting transfusable granulocytes by gravity leukopheresis
DE3029307A1 (de) 1980-08-01 1982-03-04 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Haemoglobin enthaltendes blutersatzmittel
US4454161A (en) * 1981-02-07 1984-06-12 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of branching enzyme, and a method for improving the qualities of food products therewith
DE3313600A1 (de) * 1983-04-14 1984-10-18 Laevosan-Gesellschaft mbH & Co. KG, Linz Plasmastreckmittel auf staerkebasis und verfahren zu ihrer herstellung
NL8902128A (nl) * 1989-08-23 1991-03-18 Avebe Coop Verkoop Prod Vertakkingsenzym en gebruik daarvan.
JP2896580B2 (ja) 1989-08-25 1999-05-31 チッソ株式会社 アミロース―リゾチームハイブリッドと活性化糖およびその製造法
DE19628705A1 (de) 1996-07-08 1998-01-15 Fresenius Ag Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe
FR2783838B1 (fr) 1998-09-25 2000-12-01 Roquette Freres Procede de preparation d'un melange d'enzymes de branchement de l'amidon extraites d'algues
AT409928B (de) 1999-08-10 2002-12-27 Tulln Zuckerforschung Gmbh Plasmaexpander, blutverdünnungsmittel und kryoprotektor, hergestellt unter verwendung von amylopektin-kartoffelstärke
JP2001294601A (ja) * 2000-04-11 2001-10-23 Akita Prefecture 高度分岐澱粉と該高度分岐澱粉の製造方法
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung

Also Published As

Publication number Publication date
CA2456507A1 (en) 2003-03-06
EP1421120B1 (de) 2007-04-25
KR100898528B1 (ko) 2009-05-20
PL369363A1 (en) 2005-04-18
ATE360651T1 (de) 2007-05-15
RO122279B1 (ro) 2009-03-30
KR20040052215A (ko) 2004-06-22
RS51420B (en) 2011-02-28
HUP0401188A2 (hu) 2004-09-28
DE50210039D1 (de) 2007-06-06
US20040157207A1 (en) 2004-08-12
CN100390203C (zh) 2008-05-28
PL209763B1 (pl) 2011-10-31
RS14704A (en) 2007-02-05
CN1545522A (zh) 2004-11-10
CA2456507C (en) 2011-05-03
AU2002325398B2 (en) 2008-02-28
WO2003018639A1 (de) 2003-03-06
HK1068356A1 (en) 2005-04-29
HUP0401188A3 (en) 2012-09-28
JP2005501930A (ja) 2005-01-20
US7393841B2 (en) 2008-07-01
RU2303984C2 (ru) 2007-08-10
PT1421120E (pt) 2007-08-03
DK1421120T3 (da) 2007-09-17
EP1421120A1 (de) 2004-05-26
DE10235954A1 (de) 2003-03-06
MXPA04001606A (es) 2005-03-07
ES2283585T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
ES2456695T3 (es) Composiciones y procedimientos para la modulación de la estructura y/o función vascular
JP4485058B2 (ja) 生体親和性ポリマー、それを含む組成物およびその使用
HK1068356A1 (en) Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods
EP3185918B1 (en) Collagen reinforced tissue grafts
BRPI0416702B8 (pt) formulação purgativa colônica em uma forma de dosagem sólida para administração oral, e, kit
BRPI0410185A (pt) composição para manter a viabilidade de um orgão e célula
WO2004009767A3 (en) Cell therapy for regeneration
RU2010117016A (ru) Хитозановая композиция
US20120009241A1 (en) Skin wound dressing and preparing method thereof
JP2008543987A (ja) 低分子量ヘパリンの製造方法
ES2732317T3 (es) Material de relleno dermocosmético y usos del mismo para fines estéticos
RU2490280C2 (ru) Смешанные эфиры масляной и муравьиной кислот и кислых полисахаридов и их получение и применение в качестве косметики для кожи
WO2015096170A1 (zh) 一种ε-聚赖氨酸水凝胶及其制备方法和应用
CN106890119A (zh) 一种复方的丰胸护肤品
Dedivitis et al. Pectoralis major musculocutaneous flap in head and neck cancer reconstruction
CN105749333B (zh) 一种透明质酸医用敷料及其制备方法
Shafizadeh et al. Chylous ascites secondary to laparoscopic donor nephrectomy
Mahoney et al. Use of obturator foramen in iliofemoral artery grafting
Kim et al. Preparation and properties of collagen/modified hyaluronic acid hydrogel for biomedical application
KR20160063154A (ko) 하이드로젤 유착방지제 및 그 제조방법
CN108686260B (zh) 一种复配防疤痕乳剂生物敷料的制备方法
CN113975464A (zh) 重建软组织-骨免疫修复环境骨膜-骨复合体及制备方法
Schmeizeisen et al. Microvascular reanastomozed allogenous iliac crest transplants for the reconstruction of bony defects of the mandible in miniature pigs
Liu et al. Laparoscopic harvest and free transplantation of great omentum flap for extensive tissue defects in complex wounds
Özkan Single osteotomized iliac crest free flap in anterior mandible reconstruction

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130807